XML 58 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Segment and Geographic Information (Tables)
 9 Months Ended
Jan. 29, 2021
Segment Reporting [Abstract]  
Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated
The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:
Segment Operating Profit
 Three months endedNine months ended
(in millions)January 29, 2021January 24, 2020January 29, 2021January 24, 2020
Cardiac and Vascular Group$994 $1,101 $2,745 $3,284 
Minimally Invasive Therapies Group890 860 2,120 2,453 
Restorative Therapies Group861 898 2,189 2,531 
Diabetes Group177 158 412 456 
Segment operating profit2,922 3,017 7,466 8,724 
Interest expense(143)(156)(783)(930)
Other non-operating income, net86 96 233 305 
Amortization of intangible assets(453)(436)(1,337)(1,317)
Corporate(398)(348)(1,222)(1,005)
Centralized distribution costs(458)(348)(1,398)(1,117)
Restructuring and associated costs(160)(97)(466)(315)
Acquisition-related items(35)(28)33 (74)
Certain litigation charges, net(122)(108)(118)(276)
IPR&D charges— — (20)— 
Exit of businesses— — — (41)
Debt tender premium and other charges— — — 7 
Medical device regulations(21)(13)(58)(31)
Contribution to Medtronic Foundation— — — (80)
Income before income taxes$1,220 $1,579 $2,329 $3,850 
Net Sales to External Customers by Geography The following table presents net sales for the three and nine months ended January 29, 2021 and January 24, 2020 for the Company's country of domicile, countries with significant concentrations, and all other countries:    
 Three months endedNine months ended
(in millions)January 29, 2021January 24, 2020January 29, 2021January 24, 2020
Ireland$25 $22 $74 $66 
United States 3,939 4,021 11,344 12,068 
Rest of world3,811 3,674 10,511 10,782 
Total other countries, excluding Ireland7,750 7,695 21,855 22,850 
Total$7,775 $7,717 $21,929 $22,916